[PDF][PDF] Vaccine-induced spike-and nucleocapsid-specific cellular responses maintain potent cross-reactivity to SARS-CoV-2 Delta and Omicron variants
F Chiuppesi, JA Zaia, K Faircloth, D Johnson, M Ly… - IScience, 2022 - cell.com
Cell-mediated immunity may contribute to providing protection against SARS-CoV-2 and its
variants of concern (VOC). We developed COH04S1, a synthetic multiantigen modified …
variants of concern (VOC). We developed COH04S1, a synthetic multiantigen modified …
[HTML][HTML] Vaccine-induced spike-and nucleocapsid-specific cellular responses maintain potent cross-reactivity to SARS-CoV-2 Delta and Omicron variants
F Chiuppesi, JA Zaia, K Faircloth, D Johnson, M Ly… - iScience, 2022 - Elsevier
Cell-mediated immunity may contribute to providing protection against SARS-CoV-2 and its
variants of concern (VOC). We developed COH04S1, a synthetic multiantigen modified …
variants of concern (VOC). We developed COH04S1, a synthetic multiantigen modified …
Vaccine-induced spike-and nucleocapsid-specific cellular responses maintain potent cross-reactivity to SARS-CoV-2 Delta and Omicron variants
F Chiuppesi, JA Zaia, K Faircloth, D Johnson… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Cell-mediated immunity may contribute to providing protection against SARS-CoV-2 and its
variants of concern (VOC). We developed COH04S1, a synthetic multiantigen modified …
variants of concern (VOC). We developed COH04S1, a synthetic multiantigen modified …
[PDF][PDF] Vaccine-induced spike-and nucleocapsid-specific cellular responses maintain potent cross-reactivity to SARS-CoV-2 Delta and Omicron variants
F Chiuppesi, JA Zaia, K Faircloth, F Wussow, S Dadwal… - academia.edu
Cell-mediated immunity may contribute to providing protection against SARS-CoV-2 and its
variants of concern (VOC). We developed COH04S1, a synthetic multiantigen modified …
variants of concern (VOC). We developed COH04S1, a synthetic multiantigen modified …
[HTML][HTML] Vaccine-induced spike-and nucleocapsid-specific cellular responses maintain potent cross-reactivity to SARS-CoV-2 Delta and Omicron variants
F Chiuppesi, JA Zaia, K Faircloth, D Johnson, M Ly… - iScience, 2022 - ncbi.nlm.nih.gov
Cell-mediated immunity may contribute to providing protection against SARS-CoV-2 and its
variants of concern (VOC). We developed COH04S1, a synthetic multiantigen modified …
variants of concern (VOC). We developed COH04S1, a synthetic multiantigen modified …
[HTML][HTML] Vaccine-induced spike-and nucleocapsid-specific cellular responses maintain potent cross-reactivity to SARS-CoV-2 Delta and Omicron variants
F Chiuppesi, JA Zaia, K Faircloth, D Johnson, M Ly… - iScience, 2022 - cell.com
Cell-mediated immunity may contribute to providing protection against SARS-CoV-2 and its
variants of concern (VOC). We developed COH04S1, a synthetic multiantigen modified …
variants of concern (VOC). We developed COH04S1, a synthetic multiantigen modified …
Vaccine-induced spike-and nucleocapsid-specific cellular responses maintain potent cross-reactivity to SARS-CoV-2 Delta and Omicron variants.
F Chiuppesi, JA Zaia, K Faircloth, D Johnson, M Ly… - Iscience, 2022 - europepmc.org
Cell-mediated immunity may contribute to providing protection against SARS-CoV-2 and its
variants of concern (VOC). We developed COH04S1, a synthetic multiantigen modified …
variants of concern (VOC). We developed COH04S1, a synthetic multiantigen modified …
[引用][C] Vaccine-induced spike-and nucleocapsid-specific cellular responses maintain potent cross-reactivity to SARS-CoV-2 Delta and Omicron variants
F Chiuppesi, JA Zaia, K Faircloth, D Johnson, M Ly… - …, 2022 - ui.adsabs.harvard.edu
Vaccine-induced spike- and nucleocapsid-specific cellular responses maintain potent cross-reactivity
to SARS-CoV-2 Delta and Omicron variants - NASA/ADS Now on home page ads icon ads …
to SARS-CoV-2 Delta and Omicron variants - NASA/ADS Now on home page ads icon ads …